440 related articles for article (PubMed ID: 26089550)
1. Fetal Radiation Dose from 18F-FDG in Pregnant Patients Imaged with PET, PET/CT, and PET/MR.
Zanotti-Fregonara P; Laforest R; Wallis JW
J Nucl Med; 2015 Aug; 56(8):1218-22. PubMed ID: 26089550
[TBL] [Abstract][Full Text] [Related]
2.
Zanotti-Fregonara P; Ishiguro T; Yoshihara K; Ishii S; Enomoto T
J Nucl Med; 2022 Oct; 63(10):1592-1597. PubMed ID: 35115366
[TBL] [Abstract][Full Text] [Related]
3. New Fetal Dose Estimates from 18F-FDG Administered During Pregnancy: Standardization of Dose Calculations and Estimations with Voxel-Based Anthropomorphic Phantoms.
Zanotti-Fregonara P; Chastan M; Edet-Sanson A; Ekmekcioglu O; Erdogan EB; Hapdey S; Hindie E; Stabin MG
J Nucl Med; 2016 Nov; 57(11):1760-1763. PubMed ID: 27261522
[TBL] [Abstract][Full Text] [Related]
4. Absorbed 18F-FDG dose to the fetus during early pregnancy.
Zanotti-Fregonara P; Jan S; Taieb D; Cammilleri S; Trébossen R; Hindié E; Mundler O
J Nucl Med; 2010 May; 51(5):803-5. PubMed ID: 20395321
[TBL] [Abstract][Full Text] [Related]
5. Fetal and maternal absorbed dose estimates for positron-emitting molecular imaging probes.
Xie T; Zaidi H
J Nucl Med; 2014 Sep; 55(9):1459-66. PubMed ID: 25024424
[TBL] [Abstract][Full Text] [Related]
6. Estimated Fetal Radiation Dose From 18 F-FDG PET/CT During the Second and Third Trimesters of Pregnancy.
Al Mansour L; Tylski P; Chene G; Plaisant F; Janier M; Bolze PA; You B; Defez D; Tordo J; Flaus A
Clin Nucl Med; 2024 Jul; 49(7):605-609. PubMed ID: 38778468
[TBL] [Abstract][Full Text] [Related]
7. Performance of whole-body integrated 18F-FDG PET/MR in comparison to PET/CT for evaluation of malignant bone lesions.
Eiber M; Takei T; Souvatzoglou M; Mayerhoefer ME; Fürst S; Gaertner FC; Loeffelbein DJ; Rummeny EJ; Ziegler SI; Schwaiger M; Beer AJ
J Nucl Med; 2014 Feb; 55(2):191-7. PubMed ID: 24309383
[TBL] [Abstract][Full Text] [Related]
8. Radiation dose to the fetus from [(18)F]-FDG administration during the second trimester of pregnancy.
Zanotti-Fregonara P; Koroscil TM; Mantil J; Satter M
Health Phys; 2012 Feb; 102(2):217-9. PubMed ID: 22217594
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive Oncologic Imaging in Infants and Preschool Children With Substantially Reduced Radiation Exposure Using Combined Simultaneous ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Imaging: A Direct Comparison to ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.
Gatidis S; Schmidt H; Gücke B; Bezrukov I; Seitz G; Ebinger M; Reimold M; Pfannenberg CA; Nikolaou K; Schwenzer NF; Schäfer JF
Invest Radiol; 2016 Jan; 51(1):7-14. PubMed ID: 26309185
[TBL] [Abstract][Full Text] [Related]
10. (S)-4-(3-18F-fluoropropyl)-L-glutamic acid: an 18F-labeled tumor-specific probe for PET/CT imaging--dosimetry.
Smolarz K; Krause BJ; Graner FP; Wagner FM; Hultsch C; Bacher-Stier C; Sparks RB; Ramsay S; Fels LM; Dinkelborg LM; Schwaiger M
J Nucl Med; 2013 Jun; 54(6):861-6. PubMed ID: 23568366
[TBL] [Abstract][Full Text] [Related]
11. FDG PET/CT of a late-term pregnant woman with breast cancer.
Hsieh TC; Wu YC; Sun SS; Chu LY; Yen KY; Kao CH
Clin Nucl Med; 2012 May; 37(5):489-91. PubMed ID: 22475901
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous whole-body PET/MR imaging in comparison to PET/CT in pediatric oncology: initial results.
Schäfer JF; Gatidis S; Schmidt H; Gückel B; Bezrukov I; Pfannenberg CA; Reimold M; Ebinger M; Fuchs J; Claussen CD; Schwenzer NF
Radiology; 2014 Oct; 273(1):220-31. PubMed ID: 24877983
[TBL] [Abstract][Full Text] [Related]
13. Improving MR sequence of 18F-FDG PET/MR for diagnosing and staging gastric Cancer: a comparison study to
Zheng D; Liu Y; Liu J; Li K; Lin M; Schmidt H; Xu B; Tian J
Cancer Imaging; 2020 Jun; 20(1):39. PubMed ID: 32546207
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of Atlas-Based Attenuation Correction for Integrated PET/MR in Human Brain: Application of a Head Atlas and Comparison to True CT-Based Attenuation Correction.
Sekine T; Buck A; Delso G; Ter Voert EE; Huellner M; Veit-Haibach P; Warnock G
J Nucl Med; 2016 Feb; 57(2):215-20. PubMed ID: 26493207
[TBL] [Abstract][Full Text] [Related]
15. Estimation of the beta+ dose to the embryo resulting from 18F-FDG administration during early pregnancy.
Zanotti-Fregonara P; Champion C; Trébossen R; Maroy R; Devaux JY; Hindié E
J Nucl Med; 2008 Apr; 49(4):679-82. PubMed ID: 18344434
[TBL] [Abstract][Full Text] [Related]
16. Clinical issues regarding misclassification by Dixon based PET/MR attenuation correction.
Kong E; Cho I
Hell J Nucl Med; 2015; 18(1):42-7. PubMed ID: 25840572
[TBL] [Abstract][Full Text] [Related]
17. Progressing Toward a Cohesive Pediatric 18F-FDG PET/MR Protocol: Is Administration of Gadolinium Chelates Necessary?
Klenk C; Gawande R; Tran VT; Leung JT; Chi K; Owen D; Luna-Fineman S; Sakamoto KM; McMillan A; Quon A; Daldrup-Link HE
J Nucl Med; 2016 Jan; 57(1):70-7. PubMed ID: 26471690
[TBL] [Abstract][Full Text] [Related]
18. 18F-FDG PET in pregnancy and fetal radiation dose estimates.
Takalkar AM; Khandelwal A; Lokitz S; Lilien DL; Stabin MG
J Nucl Med; 2011 Jul; 52(7):1035-40. PubMed ID: 21680687
[TBL] [Abstract][Full Text] [Related]
19. Defining optimal tracer activities in pediatric oncologic whole-body
Gatidis S; Schmidt H; la Fougère C; Nikolaou K; Schwenzer NF; Schäfer JF
Eur J Nucl Med Mol Imaging; 2016 Dec; 43(13):2283-2289. PubMed ID: 27565153
[TBL] [Abstract][Full Text] [Related]
20. Fetal Dose from PET and CT in Pregnant Patients.
Burton CS; Frey K; Fahey F; Kaminski MS; Brown RKJ; Pohlen JM; Shulkin BL
J Nucl Med; 2023 Feb; 64(2):312-319. PubMed ID: 36215573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
